Internal Medicine, Nephrology · Fresh Meadows, NY
NPI
1568438570
Since 2006
Specialty
Internal Medicine, Nephrology
Code 207RN0300X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
160 - 40 78th Road, 2nd Floor
Fresh Meadows, NY, 11366
Phone (347) 475-0911
Groups this clinician bills Medicare through
Medicare paid, 2024
$410K
2,659 services
Medicare patients, 2024
501
Average age 75
Drug cost, 2024
$1.3M
3,106 prescriptions
Company payments, 2025
$43K
From 24 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Narayan D Agrawal was code 99232 (hospital e&m - subsequent), 1,111 times for 255 patients. In total Narayan D Agrawal billed 2,659 services in 18 codes, and Medicare paid $410K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2019-06-17.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99232 Hospital E&M - Subsequent | Facility | 1,111 | 255 | $74.27 | $83K |
| 90960 ESRD Related Services (not dialysis) | Office | 568 | 103 | $321.73 | $183K |
| 99233 Hospital E&M - Subsequent | Facility | 264 | 106 | $111.45 | $29K |
| 99214 Office E&M - Established | Office | 214 | 105 | $117.28 | $25K |
| 99223 Hospital E&M - Initial | Facility | 104 | 95 | $164.24 | $17K |
| 99222 Hospital E&M - Initial | Facility | 93 | 79 | $122.81 | $11K |
| 90961 ESRD Related Services (not dialysis) | Office | 92 | 52 | $269.98 | $25K |
| 99215 Office E&M - Established | Office | 46 | 30 | $165.62 | $7,619 |
| 99213 Office E&M - Established | Office | 22 | 15 | $84.24 | $1,853 |
| 99204 Office E&M - New | Office | 19 | 19 | $161.06 | $3,060 |
| 90962 ESRD Related Services (not dialysis) | Office | 14 | 12 | $187.13 | $2,620 |
By year: 2022 $442K for 2,690 services; 2023 $344K for 2,033 services; 2024 $410K for 2,659 services.
Medicare prescription drug claims, 2024
In 2024, the drug Narayan D Agrawal prescribed most often to Medicare patients was Losartan Potassium, with 206 prescriptions and refills. In total Narayan D Agrawal wrote 3,106 Medicare prescriptions that cost $1.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Losartan Potassium Generic | 206 | 581 | 87 | $1,959 |
| Calcium Acetate Generic | 206 | 485 | 77 | $16K |
| Sevelamer Carbonate Generic | 189 | 388 | 67 | $44K |
| Farxiga Dapagliflozin Propanediol | 184 | 407 | 61 | $217K |
| Jardiance Empagliflozin | 168 | 352 | 57 | $199K |
| Prosol Parenteral Amino Acid 20% No.1 | 164 | 164 | Under 11 | $28K |
| Amlodipine Besylate Generic | 159 | 418 | 69 | $829 |
| Calcitriol Generic | 142 | 404 | 61 | $2,407 |
| Furosemide Generic | 138 | 372 | 63 | $703 |
| Kerendia Finerenone | 134 | 264 | 37 | $163K |
| Lokelma Sodium Zirconium Cyclosilicate | 133 | 249 | 49 | $145K |
| Veltassa Patiromer Calcium Sorbitex | 127 | 271 | 50 | $244K |
| Nifedipine Er Nifedipine | 117 | 296 | 47 | $3,963 |
| Hydralazine Hcl Generic | 112 | 287 | 46 | $2,141 |
| Allopurinol Generic | 61 | 177 | 25 | $621 |
Brand drugs: - claims; generic drugs: 1,983 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Narayan D Agrawal $43K ($43K in general payments such as food, travel and fees) from 24 companies. The largest payer was Travere Therapeutics, Inc. with $11K.
| Company | Payments | Amount |
|---|---|---|
| Travere Therapeutics, Inc. TVTX | 18 | $11K |
| Aurinia Pharma U.S., Inc. AUPH | 16 | $7,748 |
| Vifor Pharma, Inc. | 23 | $7,701 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 15 | $7,431 |
| Lilly USA, LLC LLY | 9 | $4,808 |
| Akebia Therapeutics Inc AKBA | 17 | $839 |
| Calliditas Therapeutics US Inc. | 17 | $528 |
| Mallinckrodt Hospital Products Inc. | 10 | $520 |
| Amgen Inc. AMGN | 14 | $395 |
| Novo Nordisk Inc NVO | 9 | $387 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.